The healthcare industry flourished during the pandemic’s height due to its role in helping the world fight against the deadly virus. Moreover, an aging population and increasing prevalence of chronic diseases brighten the industry’s prospects.
While the broader market is witnessing a sell-off with rising fears of recession due to the Fed’s aggressive interest rate hikes, medical stocks remained relatively stable because of the inelastic demand for medical products and services.
